FIBCD1: A Potential Drug Target and Biomarker (G84929)

Target Name: FIBCD1

NCBI ID: G84929

FIBCD1

Other Name(s): Fibrinogen C domain containing 1, transcript variant 1 | FBCD1_HUMAN | FIBCD1 variant 1 | Fibrinogen C domain-containing protein 1 | fibrinogen C domain containing 1

FIBCD1: A Potential Drug Target and Biomarker

Fibrinogen is a protein that plays a critical role in the body's blood clotting system. It is synthesized in the liver and stored in the liver and other tissues. When a blood vessel is damaged or sliced, fibrinogen is released to help form a clot to stop the bleeding. Fibrinogen is also involved in the regulation of cellular signaling pathways, including the TGF-β pathway.

FIBCD1 is a gene that encodes a protein with a specific domain called the C domain. The C domain is a unique structural feature that is found in only a small number of proteins. It is composed of a specific sequence of amino acids that is responsible for the protein's unique structure and function. The C domain is also known as the Fibrinogen-specific domain or the Type XIII domain.

FIBCD1 has been identified as a potential drug target and biomarker for a variety of diseases. One of the main reasons for its potential as a drug target is its involvement in the regulation of cellular signaling pathways. The TGF-β pathway is a well-established target for many diseases, including cancer, and it is possible that Fibrinogen may be involved in this pathway as well.

Studies have shown that Fibrinogen can interact with the TGF-β receptor, which is a protein that plays a role in regulating cell growth, cell differentiation, and cell survival. When the TGF-β receptor is activated, it can cause Fibrinogen to bind to the receptor and stimulate it to activate a signaling pathway that regulates cellular growth and differentiation.

In addition to its involvement in the TGF-β pathway, Fibrinogen may also be involved in the regulation of other cellular signaling pathways that are important for human health. For example, Fibrinogen has been shown to be involved in the regulation of the Wnt signaling pathway, which is important for the development and maintenance of tissues in the body.

As a potential drug target, Fibrinogen may be used to treat a variety of diseases. For example, it may be used to treat cancer, as it has been shown to have anti-tumor effects in cell studies. Fibrinogen has also been shown to have anti-inflammatory effects, which may make it a useful tool for treating diseases that are characterized by inflammation, such as rheumatoid arthritis.

In addition to its potential therapeutic applications, Fibrinogen may also be used as a biomarker for a variety of diseases. For example, it has been shown to be elevated in the blood of people with certain types of cancer, which may make it a useful marker for monitoring the effectiveness of cancer treatments.

Overall, Fibrinogen is a protein that has important roles in the body's blood clotting system and in the regulation of cellular signaling pathways. As a potential drug target and biomarker, Fibrinogen may be a valuable tool for the development of new treatments for a variety of diseases.

Protein Name: Fibrinogen C Domain Containing 1

Functions: Acetyl group-binding receptor which shows a high-affinity and calcium-dependent binding to acetylated structures such as chitin, some N-acetylated carbohydrates, and amino acids, but not to their non-acetylated counterparts. Can facilitate the endocytosis of acetylated components

The "FIBCD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FIBCD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets